TiffanyElisseSchwasinger-SchmidtMDPhD

Internal Medicine • Wichita, KS

Preventive Medicine, Obesity Medicine & Nutrition

Associate Professor of Medicine

Join to view full profile

Dr. Schwasinger-Schmidt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Schwasinger-Schmidt's full profile

Already have an account?

Office
1010 N Kansas St
Ste 3049
Wichita, KS 67214
Phone+1 316-293-2665

Fax+1 316-293-2657

Summary

Dr. Tiffany Schwasinger-Schmidt is a healthcare provider based in Wichita, KS, specializing in internal medicine with sub-specialties in preventive medicine, obesity medicine, and nutrition. She completed her medical training at the University of Kansas School of Medicine and her residency there. Currently, she serves as an Associate Professor at the same institute. Her expertise includes diabetes, clinical research, internal medicine, cognitive disorders, and clinical trials. She has several scientifically acclaimed publications and has led multiple clinical trials. Recognized for her work in the field, she has received numerous awards including the Excellence in Healthcare Award and the Women Who Lead Healthcare Award.

Education & Training

University of Kansas (Wichita)Residency, Internal Medicine, 2014 - 2017
University of Kansas School of MedicineClass of 2014
University of Nebraska-LincolnPhD, Genetics, Genomics and Bioinformatics, 2006 - 2010

Certifications & Licensure

KS State Medical License 2017 - 2025
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

Excellence in Healthcare Award Wichita Business Journal, 2022
Early Career Achievement in Medicine Alumni Award University of Kansas School of Medicine, 2022
Women Who Lead Healthcare Award Wichita Business Journal, 2021
Emerging Leaders in Wichita Program Awardee Wichita Business Journal, 2021
40 under 40 Wichita Business Journal, 2021
Wichita Business Journal Innovation Award Wichita Business Journal, 2021
Faculty Investigator Research Award University of Kansas Medical Center, 2020
Healthcare Hero Award in Healthcare Education Wichita Business Journal, 2020
Early Career Physician of the Year American College of Physicians Kansas Chapter, 2019
Resident Poster Young Investigator Award American Association of Clinical Endocrinologists, 2017
Resident Travel Grant Award American Association of Clinical Endocrinologists, 2017
Young Investigator Award National Lipid Association, 2009
Join now to see all

Clinical Trials

TrialNet Pathway to Prevention of T1D Start of enrollment: 2004 Feb 01
Recruiting
Therapy in Amyotrophic Lateral Sclerosis (TAME) Start of enrollment: 2018 Nov 07
Completed
Phase 2
SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study Start of enrollment: 2015 Sep 01
Completed
Phase 2
A Long-term Safety Study of Esketamine Nasal Spray in Treatment-resistant Depression Start of enrollment: 2016 Jun 09
Completed
Phase 3
Comparative Effectiveness Research Trial for Antidepressant Incomplete and Non-responders With TRD Start of enrollment: 2017 May 01
Completed
Phase 4
A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Subjects With Early Alzheimer's Disease_ Start of enrollment: 2016 Dec 29
Active, not recruiting
Phase 3
ACTIV-6: COVID-19 Study of Repurposed Medications Start of enrollment: 2021 Jun 08
Active, not recruiting
Phase 3
Escitalopram for Agitation in Alzheimer's Disease Start of enrollment: 2018 Jan 03
Active, not recruiting
Phase 3
A Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Alzheimer's Disease Agitation Start of enrollment: 2021 Jun 17
Enrolling by invitation
Phase 3
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation Start of enrollment: 2022 Sep 06
Recruiting
Phase 3
A Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With Depression Start of enrollment: 2020 Nov 20
Completed
Phase 2
A Study of SARS CoV-2 Infection and Potential Transmission in Individuals Immunized With Moderna COVID-19 Vaccine Start of enrollment: 2021 Mar 24
Completed
Phase 3
Metformin in Alzheimer's Dementia Prevention Start of enrollment: 2021 Mar 22
Recruiting
Phase 2, Phase 3
Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study Start of enrollment: 2022 Dec 16
Active, not recruiting
Phase 2, Phase 3
Phase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 Infection Start of enrollment: 2023 Jun 09
Recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

A 40-week phase 2B randomized, multicenter, double-blind, placebo-controlled study evaluating the safety and efficacy of memantine in amyotrophic lateral sclerosis.
Salman Bhai, Todd Levine, Dan Moore, Robert Bowser, Andrew J Heim
Muscle & Nerve. 2025-01-01
1 citations
Time to Sustained Recovery Among Outpatients With COVID-19 Receiving Montelukast vs Placebo: The ACTIV-6 Randomized Clinical Trial.
Russell L Rothman, Thomas G Stewart, Ahmad Mourad, David R Boulware, Matthew W McCarthy
JAMA Network Open. 2024-10-01
A service-oriented approach to clinical trial recruitment for dementia and brain health: Methods and case examples of MyAlliance for Brain Health.
Eric D Vidoni, Emma Swinford, Kelli Barton, Jaime Perales-Puchalt, C Michelle Niedens
Alzheimer's & Dementia. 2024-06-20

Journal Articles

Impact of a Community-Based Weight Loss Program on Renal Function
Tiffany E. Schwasinger-Schmidt, Georges Elhomsy, Bobbie Paull-Forney, Cereus, 5/13/2020

Authored Content

Inhaled fluticasone furoate for outpatient treatment of covid-19September 2023

Press Mentions

US Research Centre Uses New Methods to Include Rural People in TrialsMay 5th, 2023
Ivermectin Shown Ineffective in Treating COVID-19, According to Multi-Site Study Including KU Medical CenterDecember 1st, 2022
Local Doctors Concerned About COVID-19 Case Surge from New Year’s CelebrationsDecember 30th, 2021
Join now to see all

Professional Memberships

American College of Physicians - ACP
Member
American Medical Association - AMA
Member
Society of General Internal Medicine - SGIM
Member
Endocrine Society - ENDO
Member
Alliance for Academic Internal Medicine - AAIM
Member